# Hypobaric Hypoxia Ameliorates Impaired Regeneration After Diabetic Skeletal Muscle Injury by Promoting HIF-1α Signaling

**Authors:** Jinrun Lin, Minghao Geng, Li Zhou, Danni Qu, Hao Lin, Jihao Xing, Ryosuke Nakanishi, Hiroyo Kondo, Noriaki Maeshige, Hidemi Fujino

PMC · DOI: 10.3390/ijms27020648 · 2026-01-08

## TL;DR

Hypobaric hypoxia improves muscle regeneration in diabetic mice by boosting HIF-1α signaling, which helps blood vessel growth and muscle repair.

## Contribution

This study reveals that hypobaric hypoxia enhances diabetic muscle regeneration through HIF-1α signaling and coordinated vascular-myogenic pathways.

## Key findings

- Hypobaric hypoxia increases HIF-1α, VEGF, and eNOS expression, promoting early myogenic and angiogenic responses.
- Hypobaric hypoxia reduces fibrosis and increases myofiber cross-sectional area in diabetic muscle.
- Angpt1/Angpt2 ratio and CD31 density improve, indicating better vascular stability and muscle recovery.

## Abstract

Diabetes mellitus severely impairs skeletal muscle regeneration after injury, limiting satellite cell activation and angiogenesis and disrupting barrier integrity while increasing fibrosis. Hypobaric hypoxia has been proposed to improve the regenerative microenvironment through hypoxia-responsive signaling, but its temporal effects and the coordination between vascular and myogenic programs in diabetic muscle remain unclear. To clarify these processes, adult male mice were divided into five groups: diabetes mellitus control (DM), cardiotoxin-injured (CTX) diabetes assessed on days 7 and 14 (CTX7, CTX14), and hypobaric-hypoxia-treated diabetic injury assessed on days 7 and 14 (H+CTX7, H+CTX14). Animals in the hypoxia groups were exposed to a hypobaric hypoxia chamber for 8 h per day for 14 days. Fibrosis, angiogenic and myogenic markers, and endothelial junctional genes were examined using histology, immunofluorescence, immunoblotting, and qRT-PCR (Quantitative Real-Time PCR). Hypobaric hypoxia on day 7 enhanced HIF-1α (hypoxia-inducible factor 1 alpha), VEGF (vascular endothelial growth factor), eNOS (endothelial nitric oxide synthas), Kdr (kinase insert domain receptor, VEGFR-2), and Angpt2 (angiopoietin-2) expression, accompanied by simultaneous endothelial sprouting and early myogenic stimulation compared to CTX7. Improvements were observed in Angpt1 (angiopoietin-1), Cdh5 (cadherin-5, VE-cadherin), Emcn (endomucin), the Angpt1/Angpt2 ratio, and CD31 density. Myogenin and MyHC (myosin heavy chain) were induced with a reduction in eMyHC (embryonic myosin heavy chain) in accordance with stabilization of endothelium and maturation of fibers, which occurred by day 14. A decrease in fibrosis and an increase in the myofiber cross-sectional area occurred. These findings suggest that hypobaric hypoxia modulates HIF-1α signaling, which in turn induces the VEGF-Kdr-eNOS pathway and the angiopoietin–Tie2–VE-cadherin pathway. Together, these pathways coordinate vascular remodeling and myogenic regeneration, ultimately improving the structural and functional recovery of diabetic muscle.

## Linked entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], NOS3 (nitric oxide synthase 3) [NCBI Gene 4846], KDR (kinase insert domain receptor) [NCBI Gene 3791], ANGPT2 (angiopoietin 2) [NCBI Gene 285], ANGPT1 (angiopoietin 1) [NCBI Gene 284], CDH5 (cadherin 5) [NCBI Gene 1003], EMCN (endomucin) [NCBI Gene 51705], myog.S (myogenin S homeolog) [NCBI Gene 373806], MYH6 (myosin heavy chain 6) [NCBI Gene 4624]
- **Diseases:** Diabetes mellitus (MONDO:0005015)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Emcn (endomucin) [NCBI Gene 59308] {aka 0610012K22Rik, Muc14}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Myog (myogenin) [NCBI Gene 17928] {aka MYF4, bHLHc3, myo}, Tek (TEK receptor tyrosine kinase) [NCBI Gene 21687] {aka Cd202b, Hyk, STK1, Tie-2, Tie2}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Angpt1 (angiopoietin 1) [NCBI Gene 11600] {aka 1110046O21Rik, Ang-1, Ang1}, Angpt2 (angiopoietin 2) [NCBI Gene 11601] {aka Agpt2, Ang-2, Ang2}, Myhc (myosin heavy chain, cardiac muscle complex) [NCBI Gene 111671], Cdh5 (cadherin 5) [NCBI Gene 12562] {aka 7B4, Cd144, VE-Cad, VECD, VEcad, Vec}, Kdr (kinase insert domain protein receptor) [NCBI Gene 16542] {aka 6130401C07, Flk-1, Flk1, Krd-1, Ly73, VEGFR-2}, Nos3 (nitric oxide synthase 3, endothelial cell) [NCBI Gene 18127] {aka 2310065A03Rik, Nos-3, eNOS, ecNOS}
- **Diseases:** Diabetes mellitus (MESH:D003920), Hypoxia (MESH:D000860), Fibrosis (MESH:D005355)
- **Chemicals:** H (MESH:D006859), CTX14 (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12840971/full.md

---
Source: https://tomesphere.com/paper/PMC12840971